Increasing resistance in Gram-positive pathogens  by unknown
SYMPOSIA, STATE OF THE ART LECTURES, WORKSHOPS 
The role of chemokines and chemokine 
receptors in the pathogenicity of HIV 
These dramatic figures have prompted intensive research to define 
the bacterial and host factors involved in the septic response. Scien- 
tists from many disciplines, including chemistry, physic\, biology, 
medical microbiology, genetics, immunology, and pharmacolog, 
have worked closely with clinicians to achieve rapid arid profound 
progress. To translate this newly acquired knowledge into clinical 
practice, clinical trials have also been performed to evaluate numerous 
new therapeutic drugs. The disappointing results of these trials have 
underscored a major lesson, namely, that sepsis constitutes an 
ml Role of chemokines and chemokine receptors 
in the pathogenicity of HIV 
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Combination chemotherapy targeting HIV-1 enzymes has led to 
major advances in the therapy of AIDS. This in turn has driven a 
scientific emphasis on  the development ofan HIV preveiitive vaccine. 
Though an appropriate goal, it cannot be done at the expense of 
developing new and better forms of therapy, since the current therapy 
is not adequate for several reasons, not the least of which are thc 
difficulties in compliance for all recipients and the economic and 
logistic virtual impossibility of the curreiit therapeutic approaches 
extremely complex syndrome and that basic and cliiiical research 
must be greatly intensified in order to illuminate the molecular 
mechanisms involved. 
The  recent development of innovative approaches for the treat- 
ment of sepsic juctify optimicni that the era of high mortality of septic 
patients inay find its end in the not too distant futurc. 
- .. 
Increasing resistance in Gram-positive 
pathogens 
reading the Third World. I believe that alternative and more bio- 
logical forms of therapy will be offsprings of basic research on  HIV 
biology and its mechanisms of disease induction. I will summarize 
efforts of our group, our collaborators, aiid in some instances of I .  
The problem of MRSA and vancomycin- 
resistant staphylococci 
others concerning two separate topics relevant to this point. 
1. Results of beta-chemokine block of HIV-1 infection, including 
results of G. Lewis, A. DeVico, and J. Burns in our institute (IHV) 
on  HIV-glycosaminoglycan interactions, its augmentation of anti- 
H .  Labischinski. Bayer AG, Pliarma Research, Wuppertal, Gcrniany 
HIV effects, and implications for therapy will be discussed as well as 
correlative results of A. Garzino-Demo, E Cocchi, and A. DeVico Staphylococci are the most frequently isolated bacteria in nosocoimal 
of IHV on  cheniokinr production and the clinical outcome in HIV- infections. A special property is their remarkable propensity to 
1-infected persons. acquire resistance to antibiotics either by plasmid-mediated gene 
2. HIV-I immune pathogenesis is not simply infection of CD4 T- transfer or by integration ofmobile genetic elements into the chronio- 
cells followed by cell death. Abundant evidence indicates that iridirect some. Today the term MRSA/E, which originally meant 
effects from viral proteins and cytohnes are likely equally or morc iiiethicillin-resistant Staplrylococcrds auretrc/epidermidis, usually indicates 
important. Rased on  detailed studies of the impaired proliferation of niultiresistance against almost all clinically available antibiotics, with 
uninfected T-cells In collaboration with D. Zdgury (who pioneered the exception of the glycopeptide-type antibiotics such as vanco- 
these approaches) and with others, we have concluded that the HIV- I myciii. Following the emergence of vancomycin-resistant entero- 
Tat protein and interferon-alpha are key determinants of this cocci and after the demonstration of the transfer of uanA resistance 
imniunosupprcssion. These results and clinical trials aimed a t  determinants under laboratory conditions, there is great fear that this 
reducing the amounts of these immunosuppressive proteins will be might also happen in the clinics. Indeed, isolation of vanconiycin- 
described. resistant S. aurrws ctrains called VKSA or  VISA has been recrntly 
described in Japan by Hiramatsu and coworkers, and subsequently 
also in the USA and some European countries. It has also been 
demonstrated that so-called heterogeneously resistant strains, which 
are difficult to detect by standard procedures and may serve as a 
precursor to homogeneously resistant VRSA, appear to be relatively 
widespread in many countries. However. the resistance mechanism(s) 
involved are differmt froin those seen in enterococci and appear to 
involve trapping ofvancomycin in the cell wall fabric and, by that, 
preventing the drug reaching its target (lipid I1 cell wall precursors). 
Epidemiology, mechanism(s) of resistance and some new therapeutic 
approaches to combat MRSAIVRSA will be discussed. 
New insights into sepsis and septic shock 
wl New insights into the pathogenesis and 
therapy of sepsis and septic shock 
E.Th. Rietschel, M. Glauser. Research Center Borstel, Borstel, 
Germany; CHUC: Lausanne, Switzerland 
wl Molecular mechanisms of resistance in Severe sepsis and septic shock are the most serious complications of 
bacterial infections. Both Gram-positive aiid Grain-negative bacteria 
can trigger these extreme inflammatory responses and, by so doing, 
Gram-positive pathogens 
€? Courvalin. Znsritrrt Pasteur, Paris, France 
Antibiotic therapy for infectious diseases exerts a sudden and strong 
selective pressure against pathogenic bacteria, as well as against the 
cause substantial morbidity and mortality. In the USA alone, over 
400 000 patients suffer from septicemia each year, and approximately 
100 000 of these patients die despite optimal intensive care and 
modern antimicrobial therapy. 
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entire microflora of the patients. Besides the improved intrinsic 
activity and broadened spectrum, the extremely high concentrations 
of antibiotics present along the route (i.e. oral) of administration are 
the major reason for the dramatic upheaval of the bacterial ecosystem. 
To cope, Gram-positive bacteria have developed strategies that 
include design as well as combination of various resistance mech- 
anisms, such as: drug efflux or impermeability, alteration of the target, 
inactivation of the antibiotic, and bypass. The majority of the 
antibiotic classes are affected by combinations of resistance mech- 
anisms. For example, tetracyclines can be effluxed outside the cell 
while the ribosomal target is protected; the same bacterium can be 
resistant to quinolones by efflux combined with either target, DNA 
gyrase 1 or topoisomerase IV, modification or sequential mutations 
in the two targets. High-level resistance to glycopeptides is due to 
synthesis of new peptidoglycan late precursors with low afinity for 
the drugs and to removal of the previous susceptible target. When 
present in the same host, the two different mechanisms usually 
contribute in more than an additive fashion to the high level of 
resistance. Various examples of this combinatorial approach to 
resistance which allows bacteria to survive very high local concen- 
trations of antibiotics at the infected site will be discussed. 
ml Standardization of molecular epidemiologic 
microbial typing in Gram-positive pathogens 
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In the past few decades, molecular technology has definitely found 
its way into the clinical microbiology laboratory DNA probing and 
amplification belong to the standard repertoire for diagnostic pur- 
poses, whereas also for molecular typing of pathogenic micro- 
organisms various procedures have been developed and implemented 
in the day-to-day routine of many medical microbiology centers. A 
current disadvantage of many of these molecular identification 
schemes is that relatively little information on typing system charac- 
teristics such as discriminatory index, reliability and reproducibility 
is available. For this reason, comparative analyses of different typing 
techniques are of pivotal importance. Aso, multicentered comparison 
of the efficacy of a single technique is as important: this will provide 
insights into assay reproducibility and the possibility for establishing 
large typing-database networks. An increasing number of studies 
describing internauonal collaborative efforts for standardization of 
typing technology are entering the public domain and many of them 
focus on Gram-positive microorganisms that have acquired multiple 
resistance against antimicrobial agents. Examples described for agents 
such as methicillin-resistant Staphylococcus atrreus, penicillin-resistant 
pneumococci and vancomycin-resistant enterococci will be discussed 
and the current gold standards will be defined. 
I F )  Resistance to streptogramins and related 
antibiotics in Gram-positive bacteria 
be an increase of the efflux of the antibiotics or a decrease in the 
binding affinities to their distinct 50s ribosome targets. A number of 
different genes encoding proteins involved in each ofthe mechanisms 
have been found in Gram-positive bacteria. The conserved regions 
of these genes have been used to design degenerate primers useful for 
their screening. The reason why some staphylococcal plasmids co- 
carry two genes encoding resistance to streptogramin A by two 
distinct mechanisms is not yet known. 
Changing treatment perceptions in 
community-acquired lower respiratory tract 
infections 
I S8 1 What antibacterial characteristics are required 
for an antibiotic used for the treatment of 
community-acquired lower respiratory tract 
infections (LRTlsl? 
B. Wiedemann. Pharmaceutical Microbioloa, University o j  Bonn, 
Germany 
A variety of pathogens are implicated in LRTIs, with the most 
important being Streptococcus pneumoniae, Haemophilux inzuenzae and 
Moraxella catarrhalis. However, while the most commonly identified 
pathogen in community-acquired pneumonia (CAP) is Streptococcus 
pneumoniae, the atypical pathogens such as Mycoplasma pneumoniae, 
Chlamydia pneumoniae and Legionella pneumoniae also play an 
important role. In acute bacterial exacerbations of chronic bronchitis, 
H .  influenzae or Streptococcus pneumoniae are identified as the causative 
pathogen more often than M .  catarrhalis or Staphylococcus aureus, while 
C. pneumoniae and M .  pneumoniae are less fkequently isolated, being 
implicated in up to 5% of cases. Ideally, therefore, empirical antibiotic 
therapy for LRTIs must provide cover for all the pathogens listed 
above, including atypical organisms. The increasing incidence of 
penicillin-resistant Strqptococcus pneumoniae in many countries may 
reduce the effectiveness of beta-lactam antibiotics, which are also not 
active against the atypical pathogens. Many strains of penicillin- 
resistant pneumococci have reduced susceptibility to other classes of 
antibiotics, particularly the macrolides, which also have weak activity 
against H. inzuenzae. In contrast, the fluoroquinolones are bacteri- 
cidal, a feature which may be important for eliminating bacteria from 
the site of infection. Grepafloxacin is one of a group of newly 
introduced fluoroquinolones with potent activity against respiratory 
pathogens, including penicillin- and macrolide-resistant pneumo- 
cocci, beta-Iactamase-producing H. infuenzae and atypical organ- 
isms. A multicenter microbiological surveillance study conducted in 
1998 in European Union countries demonstrated that resistance to 
grepafloxacin in respiratory pathogens is very low: 100% of H. 
infuenrae (n=586) and M .  catarrhalis (n=510) strains, 99.5% of 
Streptococcus pneumoniae (n= 1252) and 98.2% of methicillin- 
susceptible Staphylococcus aureus strains. 
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Well-characterized mechanisms of resistance to streptogramins 
involve either streptogramin inactivation by streptogramin A acetyl- 
transferases and streptograminj3 lactonases or the alteration of the 23s 
rRNA by adenine methylases, which inhibits binding of strepto- 
gramin B, macrolides and lincosamides to their targets. The 
mechanism of resistance to streptogramin A or to streptogramin B 
conferred by related ATP-binding proteins remains unclear. It could 
L s9 I Pharmacokinetics and pharmacodynamics of 
the fluroquinolones: how important is tissue 
penetration? 
D. Honeybourne. Birmingham Heartland Hospiral, Dept. of 
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The efficacy of an antibiotic is closely related to its pharmacokinetic 
and pharmacodynamic features. In respiratory tract infections, 
pharmacokinetics and pharmacodynamics are relevant at a number of 
